ELV
Elevance Health, Inc.
Latest Form 4:Purchase$1.0MbyBOUDREAUX GAIL (President and CEO) · filed Jul 17, 2026
Elevance Health, Inc. (ELV) has 33 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 17, 2026.
Insiders have net bought $493K over the trailing 6 months. The largest single insider purchase in this window was $1.0M by President and CEO BOUDREAUX GAIL on Jul 17, 2026.
- Industry:Medical - Healthcare Plans
- CEO:Gail Koziara Boudreaux
- Employees:97,100
- HQ:Indianapolis, IN, US
- IPO:2001-10-30
Insider Buying
$2.2M
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$85.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
BOUDREAUX GAILFirst filing | President and CEO | Purchase | 2,725 | $1.0M | Jul 17 | SEC ↗ |
| Director | Purchase | 1,000 | $366K | Jul 17 | SEC ↗ | |
| CAO & Controller | Sale | 369 | $149K | Jun 15 | SEC ↗ | |
Dixon Robert L JRFirst filing | Director | Sale | 151 | $61K | Jun 12 | SEC ↗ |
Penczek Ronald WFirst filing | CAO & Controller | Sale | 1,531 | $617K | May 20 | SEC ↗ |
SCHULMAN AMY WFirst filing | Director | Sale | 26 | $7K | Mar 23 | SEC ↗ |
Kendrick Charles Morgan JRFirst filing | EVP & President, Commercial | Sale | 3,196 | $911K | Mar 9 | SEC ↗ |
| Director | Purchase | 3,000 | $870K | Mar 6 | SEC ↗ |
Related companies
Elevance Health, Inc. is in the Finance & Insurance sector.